Source: Cytel Inc. – Bill and Melinda Gates Foundation

Together with the Bill and Melinda Gates Foundation, Cytel has launched an open-access global COVID-19 Clinical Trial Tracker. The objective is to encourage further collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other stakeholders while also informing them about options for testing and treatments in their area.

The dashboard offers an overview of all trials taking place around the world making it easier for stakeholders to compare the effectiveness of treatments and avoid duplication of efforts.